BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 6141083)

  • 21. A prospective controlled study of the effect on blood pressure of contraceptive preparations containing different types and dosages of progestogen.
    Wilson ES; Cruickshank J; McMaster M; Weir RJ
    Br J Obstet Gynaecol; 1984 Dec; 91(12):1254-60. PubMed ID: 6440589
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Changes in coagulation and anticoagulation in women taking low-dose triphasic oral contraceptives: a controlled comparative 12-month clinical trial.
    Notelovitz M; Kitchens CS; Khan FY
    Am J Obstet Gynecol; 1992 Nov; 167(5):1255-61. PubMed ID: 1442974
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Estrogen metabolism and hormone substitution in the climacteric].
    Göretzlehner G; Kyank H
    Zentralbl Gynakol; 1985; 107(16):977-88. PubMed ID: 2996259
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The effect of hormone replacement therapy on vitamin E status in postmenopausal women.
    Wen Y; Doyle MC; Harrison RF; Feely J
    Maturitas; 1997 Mar; 26(2):121-4. PubMed ID: 9089561
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of long-term continuous combined hormone replacement therapy with estradiol valerate and either dienogest or norethisterone acetate on mammographic density in postmenopausal women.
    Georgiev DB; Manassiev NA
    Medscape Womens Health; 2002; 7(4):1. PubMed ID: 12466733
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The effect of hormone replacement therapy on the oxidation of low density lipoprotein in postmenopausal women.
    Mc Manus J; Mc Eneny J; Thompson W; Young IS
    Atherosclerosis; 1997 Nov; 135(1):73-81. PubMed ID: 9395275
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Combined oral oestradiol valerate-norethisterone treatment over three years in postmenopausal women: correlation between oestrogen levels and bone mineral density sites.
    Perry W; Wiseman RA
    BJOG; 2000 Nov; 107(11):1401-6. PubMed ID: 11117769
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Dose-dependent effects of synthetic progestins on the biochemistry of the estrogenized post-menopausal endometrium.
    Siddle NC; Townsend PT; Young O; Minardi J; King RJ; Whitehead MI
    Acta Obstet Gynecol Scand Suppl; 1981; 106():17-22. PubMed ID: 6281330
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Basic principles of hormone replacement therapy in the postmenopause].
    Dören M
    Ther Umsch; 2000 Oct; 57(10):628-34. PubMed ID: 11081374
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Continuous-combined treatment of the menopause with combinations of oestradiol valerate and dienogest - a dose-ranging study.
    Gräser T; Müller A; Mellinger U; Mück AO; Lippert TH; Oettel M
    Maturitas; 2000 Jun; 35(3):253-61. PubMed ID: 10936742
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Differential clinical response to oestrogens after menopause.
    Wren BG; Brown LB; Routledge DA
    Med J Aust; 1982 Oct; 2(7):329-32. PubMed ID: 6292676
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Continuous combined hormone replacement therapy compared with tibolone.
    Al-Azzawi F; Wahab M; Habiba M; Akkad A; Mason T
    Obstet Gynecol; 1999 Feb; 93(2):258-64. PubMed ID: 9932566
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Combined oral estradiol valerate-norethisterone treatment over 3 years in postmenopausal women: effect on lipids, coagulation factors, haematology and biochemistry.
    Perry W; Wiseman RA
    Maturitas; 2002 Jun; 42(2):157-64. PubMed ID: 12065175
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Question of a Colleague. Can I still give advice to my wife about hormone replacement?].
    Seifert-Klauss V
    MMW Fortschr Med; 2002 Oct; 144(44):18. PubMed ID: 12494594
    [No Abstract]   [Full Text] [Related]  

  • 35. A double-blind cross-over study of piperazine oestrone sulphate and placebo with coagulation studies.
    Poller L; Thomson JM; Coope J
    Br J Obstet Gynaecol; 1980 Aug; 87(8):718-25. PubMed ID: 7000169
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The differential effect of estrogen, estrogen-progestin and tibolone on coagulation inhibitors in postmenopausal women.
    Keramaris NC; Christodoulakos GE; Lambrinoudaki IV; Dalamanga A; Alexandrou AP; Bramis J; Bastounis E; Creatsas GC
    Climacteric; 2007 Oct; 10(5):400-7. PubMed ID: 17852143
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparison of serum oestrogen concentrations in post-menopausal women taking oestrone sulphate and oestradiol.
    Anderson AB; Sklovsky E; Sayers L; Steele PA; Turnbull AC
    Br Med J; 1978 Jan; 1(6106):140-2. PubMed ID: 620226
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The effect of different regimens of oestrogens on the clotting and fibrinolytic system of the post-menopausal woman.
    Thom M; Dubiel M; Kakkar VV; Studd JW
    Front Horm Res; 1977; 5():192-202. PubMed ID: 208880
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Ovarian function during oestrogen-progestin replacement treatment in pre-menopausal women.
    Ylöstalo P; Vartiainen E; Stenman UH; Widholm O
    Maturitas; 1986 Mar; 8(1):19-27. PubMed ID: 3010055
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Is oestrogen therapy effective in the treatment of menopausal depression?
    Coope J
    J R Coll Gen Pract; 1981 Mar; 31(224):134-40. PubMed ID: 6268783
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.